Skip to main content

ANGIODYNAMICS INC

corporate_fare Company Profile

ANGIODYNAMICS INC

ANGO·NASDAQ·Healthcare·CIK 0001275187

AngioDynamics is a diversified medical technology company that designs, manufactures, and sells products and technologies to aid clinicians in treating patients with cardiovascular disease and cancer diagnoses. The company was founded in Queensbury, N.Y., U.S., in 1988 and began manufacturing and shipping products in the early 1990s. Its headquarters are in Latham, N.Y., with manufacturing primarily in Queensbury. Initially focused on interventional radiology products, AngioDynamics became a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Over the years, the company expanded through acquisitions. These included RITA Medical Systems in January 2007, Oncobionic in May 2008, the assets of Diomed in June 2008, Vortex Medical, Inc. in October 2012, the assets of Microsulis Medical Limited in January 2013, and Clinical Devices in August 2013. These acquisitions added product lines such as ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, embolization products, and venous products. In September 2018, AngioDynamics acquired RadiaDyne, which included endorectal and vaginal balloons. On October 2, 2019, the company acquired Eximo Medical, Ltd., and its proprietary 355nm laser atherectomy technology (now called Auryon), which treats Peripheral Artery Disease. On December 17, 2019, it acquired the C3 Wave tip location asset from Medical Components Inc. On July 27, 2021, AngioDynamics acquired the Camaro Support Catheter asset from QX Medical, LLC. The company sold its Fluid Management business (acquired in May 2012 from Navilyst Medical) in May 2019 to Medline Industries, Inc., and the BioSentry product line (acquired in August 2018 from Surgical Specialties, LLC) in June 2023 to Merit Medical Systems, Inc.

ANGIODYNAMICS INC (NASDAQ:ANGO) is a publicly traded company in the Healthcare sector. Wiseek monitors ANGO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Angiodynamics' NanoKnife IRE System Shows Durable Two-Year Outcomes in Prostate Cancer Trial
  • AngioDynamics Sues Rival Endovascular Engineering Over Hēlo System Patent Infringement
  • AngioDynamics Initiates Patent Infringement Lawsuit Against Competitor Endovascular Engineering
  • AngioDynamics Reports Strong Q3 Sales, Improved YTD Loss, and Favorable Patent Ruling
  • AngioDynamics Reports Strong Q3 Results, Raises Full-Year Guidance for Third Consecutive Quarter

Financial Snapshot

Fiscal year ended May 31, 2025
Revenue
$292.5M
Net Income
-$33.99M
Diluted EPS
-$0.83
Op. Cash Flow
-$10.13M
Free Cash Flow
-$14.59M
Gross Profit
$157.71M
Operating Income
-$39.95M
Cash & Equivalents
$55.89M
Debt / Equity
0.00×
Net Margin
-11.6%
Shares Outstanding
40.99M sh
Source: 10-K · filed 2025-07-18 · accession 0001275187-25-000014
Browse all tickers starting with A →
$12.1
52-week range · as of 2026-04-23 $8.36 – $13.99
Market cap
$499.96M
Volume
229.6K (0.8× avg)
3-mo avg 292.8K
Live data · 2026-06-13 13:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ANGO - Latest Insights

ANGO
May 13, 2026, 9:06 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.84
Real-time Price: $12.10 info
Change: +$1.26 (+12%) info
Market Cap: $499.959M info
ANGO
Apr 23, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.20
Real-time Price: $12.10 info
Change: +$0.900 (+8%) info
Market Cap: $499.959M info
ANGO
Apr 23, 2026, 4:59 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.20
Real-time Price: $12.10 info
Change: +$0.900 (+8%) info
Market Cap: $499.959M info
ANGO
Apr 02, 2026, 1:56 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.47
Real-time Price: $12.10 info
Change: +$1.63 (+16%) info
Market Cap: $499.959M info
ANGO
Apr 02, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.97
Real-time Price: $12.10 info
Change: +$0.1323 (+1%) info
Market Cap: $499.959M info
ANGO
Apr 02, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $12.20
Real-time Price: $12.10 info
Change: -$0.100 (-0.82%) info
Market Cap: $499.959M info
ANGO
Feb 03, 2026, 5:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.43
Real-time Price: $12.10 info
Change: +$1.67 (+16%) info
Market Cap: $499.959M info
ANGO
Jan 14, 2026, 7:33 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.28
Real-time Price: $12.10 info
Change: +$1.82 (+18%) info
Market Cap: $499.959M info
ANGO
Jan 06, 2026, 3:19 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.84
Real-time Price: $12.10 info
Change: +$1.26 (+12%) info
Market Cap: $499.959M info
ANGO
Jan 06, 2026, 7:16 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.99
Real-time Price: $12.10 info
Change: -$1.89 (-14%) info
Market Cap: $499.959M info